Impact Dashboard - August 2014

Similar documents
Impact Dashboard - October 2014

impact dashboard year-end with 2017 coefficients

impact dashboard - september 2018

impact dashboard - august 2018

impact dashboard - june 2018

impact dashboard - may 2018

October 2011 Monthly Health Impact Report

February Health Impact Report 2010

Annex 2 A. Regional profile: West Africa

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Eligibility List 2018

2015 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

CONTRACEPTIVE SOCIAL MARKETING STATISTICS

2002 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

2006 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

2007 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

Global Fund ARV Fact Sheet 1 st June, 2009

Sexual and reproductive health care: A comparison of providers and delivery points between the African Region and other regions

Comparative Analyses of Adolescent Nutrition Indicators

JOINT TB AND HIV PROGRAMMING

Global Fund Results Fact Sheet Mid-2011

THE CARE WE PROMISE FACTS AND FIGURES 2017

SGCEP SCIE 1121 Environmental Science Spring 2012 Section Steve Thompson:

2009 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

Tipping the dependency

2010 CONTRACEPTIVE SOCIAL MARKETING STATISTICS

Family Planning: Succeeding in Meeting Needs To Make a Better World. Amy Tsui April 12, 2011

ANNEX 3: Country progress indicators

Global Fund Mid-2013 Results

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

BCG. and your baby. Immunisation. Protecting babies against TB. the safest way to protect your child

Challenges and Opportunities to Optimizing the HIV Care Continuum Can We Test and Treat Enough People to Make a Seismic Difference by 2030?

Main global and regional trends

ICM: Trade-offs in the fight against HIV/AIDS

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

Financing malaria control

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

UNAIDS Office on AIDS, Security and Humanitarian Response; Initiative on HIV/AIDS and Uniformed Services, with special emphasis on young recruits

Lessons learned from the IeDEA West Africa Collaboration

Various interventions for controlling sexually transmitted infections have proven effective, including the syndromic

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS

Global summary of the AIDS epidemic, December 2007

מדינת ישראל. Tourist Visa Table

Seizures of ATS (excluding ecstasy ), 2010

Sourcing of ARVs & HIV diagnostics. Procurement for Impact P4i

Update from GAVI Aurelia Nguyen

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

Drug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )

Maternal Deaths Disproportionately High in Developing Countries

Epidemiology and economics: modelling the scenarios for the end of AIDS

Diagnostic Procurement The Clinton Foundation HIV/AIDS Initiative

World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts

Global reductions in measles mortality and the risk of measles resurgence

Outcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations

1. Consent for Treatment This form must be completed in order to receive healthcare services in the campus clinic.

Donor Support for Contraceptives and Condoms for STI/HIV Prevention

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)

D TA companion & Scorecard. to the UNICEF Gender Action Plan. May 2016

#1 #2 OR Immunity verified by immune titer (please attach report) * No titer needed if proof of two doses of Varicella provided

The Global HIV/AIDS Epidemic, risk factors for transmission. and Global response. Training Course in Sexual and Reproductive Health Research 2014

HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR

Rotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division

THE FUTURE OF ADULT MORTALITY UNDER THE AIDS THREAT: ESTIMATING AND PROJECTING INCIDENCE; PROJECTING MORTALITY WITH HIV/AIDS *

UNAIDS 2013 AIDS by the numbers

Update on progress of MPP sublicensees

IX. IMPROVING MATERNAL HEALTH: THE NEED TO FOCUS ON REACHING THE POOR. Eduard Bos The World Bank

AIDS in Africa. An Update. Basil Reekie

What is this document and who is it for?

511,000 (57% new cases) ~50,000 ~30,000

This portion to be completed by the student Return by July 1 Please use ballpoint pen

Certificate of Immunization

Ending the AIDS Epidemic in Adolescents

Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, 2000)

The Private Sector: Key to Achieving Family Planning 2020 Goals

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

WORLD COUNCIL OF CREDIT UNIONS 2017 STATISTICAL REPORT

UNAIDS 2017 REFERENCE UNAIDS DATA 2017

Methodological issues in the use of anthropometry for evaluation of nutritional status

Rotavirus vaccines: Issues not fully addressed in efficacy trials

O c t o b e r 1 0,

To Tie the Knot or Not: A Case for Permanent Family Planning Methods

Access to Stigma-Free Healthcare Settings for Key Populations: Challenges and Opportunities

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012

Presentation by Dr Philippe Douste-Blazy. Chair of UNITAID Special Representative of the UN SG for Innovative Financing for Development

DATA COMPANION & & SCORECARD. to the UNICEF Gender Action Plan. May 2017

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

HIV in Women: A Global View of the HIV Epidemic

U.S. Funding for International Family Planning & Reproductive Health

MATERNAL, NEWBORN, AND CHILD HEALTH

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

HIV in Women: A Global View of the HIV Epidemic

Transcription:

Impact Dashboard - By, PSI and its network members averted an estimated 29.7 million DALYs globally. PSI has met 53.3% of the strategic plan (SP) target to avert 198.7 million DALYs, and 53.0% of the SP target to provide 105.6 million CYPs; with 53.3% elapsed time. 2014 DALYs averted from nine countries accounted for 77% of DALYs averted and each accounted for > 1 millions DALYs averted, see page 3. DALYs averted from sold, male condoms are lagging 14% behind the 2014 target and distribution has decreased 22% relative to 2013, note India and Congo-Kinshasa. By far, our biggest CYP producers are Nigeria, Kenya, and Pakistan; total of 41% of CYPs provided and each accounted for > 1 million CYPs, see page 5. PSI PROGRESS ON SCALE August SP to date SP Target % SP Target DALYs 3,507,662 29,677,871 17% 105,971,074 198,700,000 53.3% CYPs 1,606,850 12,413,763-18% 55,971,986 105,600,000 53.0% PSI Health Relevance 24.73% PSI Burden 1.59% PSI PROGRESS TOWARD STRATEGIC PLAN (SP) TARGETS IN DALYS AVERTED AND CYPS PSI 2014 Target: 25% increase in DALYs averted relative to 2007-2011 Target: 30% increase in CYPs relative to 2007-2011 Million ion DALYs averted 200 150 100 50-2007-2011 Baseline (158.9 million DALYs averted) 2012-2016 Performance (106.0 million DALYs averted) Million ion CYPs Provided 120 100 80 60 40 2012-2016 SP Target 20 (198.7 million DALYs averted) - PSI REGIONAL AND HEALTH AREA PERFORMANCE Region August DALYs DALYs % of 2014 Program Target* CYPs Provided 2007-2011 Baseline (81.3 million CYPs) Strategic Plan Time Elapsed 53.3% (32/60 months) 2012-2016 Performance (56.0 million CYPs) 2012-2016 SP Target (105.6 million CYPs) % of 2014 Program Target* West & Central Africa 1,691,939 14,622,821 48% 70% 413,734 3,212,878-25% 55% East Africa 959,308 7,932,291-10% 78% 528,464 3,810,761 37% 90% Southern Africa 711,617 5,917,666 35% 58% 321,764 2,288,601 7% 64% Latin America & Caribbean 13,080 106,877-1% 62% 59,127 485,340 0% 60% Asia & Eastern Europe 131,718 1,098,217-49% 33% 283,761 2,616,183-52% 32% TOTAL 3,507,662 29,677,871 17% 66% 1,606,850 12,413,763-18% 55% Health Area 2007-2011 2012-2016 August DALYs DALYs Burden HIV, STD, Hepatitis B&C, Opioid Use 980,272 7,117,557 5% 51 of 53 6.81% Tuberculosis 13,866 93,929 4% 8 of 53 0.27% Reproductive Health 670,932 5,085,568-13% 52 of 53 3.63% Malaria 1,775,624 16,723,446 46% 27 of 53 14.32% Diarrhea Diseases 33,621 372,321 11% 29 of 53 0.54% Nutritional Deficiencies 25 219-31% 6 of 53 0.00% Respiratory Infections 33,322 284,830-64% 5 of 53 0.37% Health areas not targeted by PSI TOTAL 3,507,662 29,677,871 17% 1.59% * 2014 program targets: 44,748,981 DALYs averted and 22,655,582 CYPs; we should be at 67% in August. 2007-2011 2012-2016 August CYPs Provided Country with Program Burden as % of PSI Global 6.81% 2.66% 8.14% 5.43% 5.25% 2.33% 5.95% 63.41% IMPACT DASHBOARD AUGUST 2014 1

PSI PROGRESS ON RELEVANCE 2014 2016 SP Target Health Relevance 24.73% 42% FP Method Mix* 52.8% (28 of 53)** 75% Mali (added burden from tuberculosis - referral to TB diagnostic) No change Notes: start reporting in this period *% platforms offering 4 or more FP modern methods with at least one long-term method (LTM), ** excluded C.A.R., China, Cote d'ivoire (AIMAS), Mexico, and Romania PSI RELEVANCE: 2010 Global Burden of Disease < Expansion & Innovation > 90% 80% 70% 60% 50% 40% 30% Current works 20% 10% 0% PSI Global Innovation in Other Health Areas: % disease burden not targeted by PSI Expansion: % disease burden targeted by existing PSI products/services plus cervical cancer, diabetes mellitus, and high blood pressure, not in use by country platform Health Relevance: % disease burden targeted by current country platform products and services Burden : % DALYs averted by PSI in 2014 as proportion of 2010 Global Burden of Disease in DALYs 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Mozambique Zimbabwe Cameroon Nigeria Zambia Swaziland Madagascar Tanzania South Africa Malawi Uganda Mali Lesotho DRC Kenya Botswana Guinea Benin Rwanda South Sudan Angola Myanmar Burundi Namibia Senegal Togo Côte d'ivoire Liberia Caribbean Pakistan India Belize Cambodia Ethiopia PNG Laos Thailand Dom Rep Guatemala Honduras Viet Nam Panama Nicaragua Tajikistan Paraguay El Salvador Kyrgyzstan yzstan Nepal Haiti Kazakhstan Costa Rica Russia PSI FP Method Mix: classified by modern method mix. FP method mix targets 4 methods + 1 long-term method (LTM) 4 or more modern methods + 1 LTM 4 or more modern methods + 1 LTM 2 modern methods Madagascar Ethiopia Papua New Guinea Nigeria Rwanda Somaliland Pakistan El Salvador South Africa Benin Nicaragua Swaziland Congo-Kinshasa Haiti Thailand Malawi India 1 short-term method Mali Laos Botswana Myanmar Liberia Costa Rica Tanzania 3 modern methods Cote d'ivoire Togo Dominican Republic Honduras Zimbabwe Nepal Kazakhstan Cambodia Belize Panama Cameroon Guinea South Sudan Mozambique Paraguay Tajikistan Uganda Senegal Vietnam Zambia 2 modern methods no FP method provided Burundi Angola Russia Guatemala Kyrgyzstan Kenya Lesotho Caribbean Namibia number of long-term methods including implants, IUDs and male/female sterilization number of short-term methods including male condom, female condom, cycle beads, EC, injectables and OC IMPACT DASHBOARD AUGUST 2014 2

COUNTRIES BY 2014 DALYS AVERTED DALYs DALYs % of 2014 DALYs Health Relevance DALYs %DALYs Nigeria 1,584,968 9,059,409 41% 93% 44.18% 24,447,104 23.1% Congo-Kinshasa 7,489 3,926,507 334% 52% 36.02% 12,832,053 12.1% South Sudan 269,496 1,764,829-48% 84% 31.99% 8,362,839 7.9% Zimbabwe 147,626 1,764,510 152% 47% 45.67% 5,202,687 4.9% South Africa 260,844 1,455,006-3% 60% 42.59% 6,012,080 5.7% Uganda 171,198 1,336,861 129% 78% 40.64% 3,495,372 3.3% Kenya 78,809 1,312,221 91% 109% 35.38% 3,451,384 3.3% Zambia 120,885 1,181,404 26% 54% 44.16% 4,928,499 4.7% Tanzania 199,618 1,066,819-7% 65% 42.64% 3,861,080 3.6% Mozambique 39,204 960,698-25% 69% 48.88% 3,890,271 3.7% Mali 14,000 908,916 39% 36% 40.55% 3,732,233 3.5% Madagascar 67,850 812,975 18% 74% 42.82% 4,157,211 3.9% Malawi 91,473 530,313-51% 60% 41.95% 3,654,639 3.4% Pakistan 34,109 478,307-47% 35% 19.82% 2,519,487 2.4% Angola 42,987 431,209 508% 112% 31.42% 956,096 0.9% Cameroon 56,614 345,637 24% 70% 44.69% 1,213,327 1.1% Lesotho 77,065 309,909 38% 123% 37.85% 870,693 0.8% Myanmar 39,046 244,473-35% 52% 31.24% 1,234,145 1.2% Ethiopia 23,077 241,521-18% 58% 16.37% 980,036 0.9% Swaziland 26,527 227,651 50% 78% 43.23% 718,461 0.7% India 36,600 214,711-64% 19% 19.34% 2,542,012 2.4% Benin 19,128 147,988 21% 69% 32.62% 555,521 0.5% Rwanda 24,769 141,641 13% 61% 32.02% 638,367 0.6% Burundi 16,332 129,591 65% 73% 30.09% 366,618 0.3% Botswana 3,109 127,396 201% 189% 34.38% 311,778 0.3% Guinea 5,929 110,570-90% 69% 32.89% 1,508,951 1.4% Cambodia 11,626 95,142-44% 47% 18.83% 673,165 0.6% Togo 1,020 56,773-13% 43% 28.40% 247,089 0.2% Senegal 1,590 47,908 69% 61% 29.30% 114,328 0.1% Namibia 7,712 38,815-68% 45% 29.56% 204,089 0.2% Haiti 3,170 27,960-6% 62% 5.01% 159,754 0.2% Guatemala 4,533 27,615 1% 56% 8.87% 117,542 0.1% Dominican Republic 2,309 22,017 3% 66% 9.06% 86,482 0.1% Somaliland 2,344 16,587 1% 62% NA 57,130 0.1% Cote d'ivoire 1,201 16,082-23% 70% 23.53% 581,764 0.5% Viet Nam 2,216 15,396 29% 64% 8.17% 83,072 0.1% Tajikistan 4,935 12,448 66% 102% 7.48% 28,574 0.0% Laos 1,862 10,151 3% 64% 13.47% 37,422 0.0% Thailand 701 9,874 30% 58% 9.16% 36,721 0.0% Nepal 348 9,072-80% 14% 5.57% 143,351 0.1% Panama 494 6,379 22% 89% 7.91% 19,217 0.0% Papua New Guinea 275 5,681 70% 98% 13.73% 22,360 0.0% Paraguay 692 5,386-1% 61% 7.00% 20,990 0.0% Honduras 694 5,139-4% 63% 8.33% 20,002 0.0% El Salvador 544 5,136 3% 67% 6.87% 23,561 0.0% Nicaragua 465 4,895 4% 61% 7.58% 20,899 0.0% Liberia 3,030-13% 34% 21.35% 14,852 0.0% Kazakhstan 1 2,934 119% 99% 3.79% 15,253 0.0% Belize 74 995-10% 51% 19.06% 4,713 0.0% Costa Rica 92 694 2% 55% 3.06% 2,852 0.0% Caribbean 10 660 74% 40% 20.35% 3,675 0.0% Kyrgyzstan 28-29% 6.49% 16,246 0.0% Russia 0 NA NA 0.00% 782 0.0% PSI GLOBAL 3,507,662 29,677,871 17% 66% 24.73% 105,971,074 * 2014 program targets: 44,748,981 DALYs averted; we should be at 67% in August. 5 Company 158** 94,943 772,705 12% NA NA 2,496,298 2.4% **included sales / distribution in Botswana, Lesotho, South Africa, and Swaziland. These sales / distribution are also included in the countries above. IMPACT DASHBOARD AUGUST 2014 3

PSI PRODUCTS & SERVICES BY 2014 DALYS AVERTED 0% Products / Services DALYs DALYs % of 2014 DALYs # Distributed Reporting 2014 CYPs LLIN 774,671 10,108,096 88% 65% 19,368,703 21 Malaria PPT (ACT) 1,000,710 6,608,435 10% 81% 11,426,115 11 Condom 690,586 5,020,934-14% 53% 512,448,365 42 4,270,403 Free Condom 262,480 2,011,487 17% 82% 162,134,521 30 1,351,121 Male Circumcision 185,235 976,616 21% 76% 273,228 9 Basic Care Package 46,597 745,270 125% 67% 14,078,163 2 OC 71,306 575,181-22% 58% 23,368,708 31 1,557,914 IUD 10 Insertion 86,334 508,083 4% 90% 236,435 22 1,087,601 Injectable 3 35,912 503,584-7% 63% 4,992,976 27 1,248,244 HIV Counseling and Testing 44,161 408,272-10% 63% 1,422,789 30 Implant 5 Insertion 58,440 365,959 42% 176% 188,815 17 717,497 Pneumonia PPT 33,322 284,830-64% 71% 448,088 5 IUD 10 Distribution 56,877 201,763-27% 40% 71,431 22 328,583 Implant 3 Distribution 15,977 178,041 1251% 604% 157,913 6 394,783 IUD 5 Insertion 22,558 159,893-6% 986% 131,536 3 434,069 IUD 5 Distribution 12,967 130,600-74% 18% 139,272 5 459,597 Diarrhea Treatment Kit 12,786 123,826 14% 51% 1,803,450 11 ORS 3,929 109,531 82% 110% 3,319,634 7 Safe Water Solution 12,277 97,568-28% 58% 6,937,629 13 TB DOTS 13,866 93,929 4% 66% 15,804 4 Female Condom 6,148 84,684 15% 86% 6,357,638 19 52,980 Injectable 2 9,529 75,972-9% 45% 948,203 4 158,034 Emergency Contraception 4,223 39,820 18% 39% 2,100,447 9 105,022 Implant 3 Insertion 8,584 39,107 117% 98% 27,233 6 68,083 SDM (Cycle Beads) 3,214 38,491 16% 65% 52,929 8 79,394 Implant 5 Distribution 8,267 26,150-81% 9% 15,999 21 60,796 Needle & Syringe 4,669 24,168 142% 75% 2,982,705 4 Water Treatment Tablets 3,730 23,054 11% 70% 47,774,085 16 STI Kit 6,795 19,757 106% 111% 402,429 6 Free Female Condom 1,887 14,109-47% 57% 992,354 12 8,270 Misoprostol for PAC (Oral) 2,424 13,601-14% 43% 796,313 5 Zinc 653 12,112 421% 320% 1,032,584 4 Medication Abortion 1,178 9,776-20% 59% 312,597 3 Naloxone 2,729 7,912 2% 80% 5,813 2 Tubal Ligation 5,404-66% 9% 1,523 1 15,230 Early Infant MC 884 5,141-47% 35% 700 1 PUR 245 4,872-28% 77% 31,184,849 10 Injectable 1 48 3,582-26% 44% 163,892 4 12,607 Malaria PPT (Non-ACT) 162 3,426-16% 60% 40,200 1 Retreatment IconMaxx 3,243-94% NA 21,519 1 Implant 4 Insertion 395 2,937 87% 12% 2,235 3 7,152 Clean Delivery Kit 84 2,661-26% 52% 35,056 5 Misoprostol for PPH 379 2,212 45% 201% 489,026 3 Skilled Birth Attendance (Facility Deliv 527 1,962 532% NA 8,442 1 LifeStraw 0 1,357 917% 1020% 7,843 1 Antiretroviral Treatment (Patient-mont 82 725 27% 37% 1,479 1 Cervical Cancer-VIA/PAP & Cryothe 52 422 360% 36% 1,418 8 IPTp2 81 247 362% 0% 5,815 1 Multivitamin 25 219 23% 73% 1,940,640 2 Implant 4 Distribution -327-1,150-166% -147% -1,130 1-3,616 Iron Folic Acid Tablet 0 - NA 0 0 Malaria RDK 0 NA NA 2,790,525 9 Micronutrient Powder 0 NA NA 1,661,140 3 Vasectomy 0% NA 0% 0 PSI GLOBAL 3,507,662 29,677,871 17% 66% 12,413,763 * 2014 program targets: 44,748,981 DALYs averted; we should be at 67% in August. IMPACT DASHBOARD AUGUST 2014 4

COUNTRIES BY 2014 CYPS PROVIDED ## CYPs CYPs % of 2014 CYPs FP Method Mix CYPs Provided % of CYPs Provided Nigeria 320,346 2,228,364 5% 60% 8,676,462 15.4% Kenya 99,497 1,498,082 126% 127% 3,523,426 6.3% Pakistan 92,575 1,315,718-48% 34% 7,052,256 12.8% Tanzania 183,938 993,755-16% 65% 3,845,883 6.7% South Africa 140,934 760,558-5% 58% 3,223,896 5.7% Uganda 173,701 722,602 108% 120% 1,961,225 3.3% Madagascar 72,278 667,868 10% 72% 2,618,669 4.7% India 95,070 531,242-68% 20% 6,745,280 12.2% Cambodia 45,081 385,439-14% 49% 1,919,809 3.5% Zambia 31,324 322,652-2% 46% 1,469,837 2.6% Myanmar 43,482 318,980-42% 58% 1,617,533 2.9% Zimbabwe 31,734 257,622 31% 62% 829,109 1.4% Mali 21,349 254,073-66% 41% 1,446,398 2.6% Cameroon 27,466 220,359 13% 54% 848,567 1.5% Benin 26,299 194,458 20% 73% 722,681 1.3% Ethiopia 12,096 169,192-22% 58% 688,659 1.2% Malawi 14,199 148,868 15% 108% 425,965 0.8% Lesotho 37,421 135,520 40% 132% 382,915 0.6% Guatemala 19,746 126,049 0% 52% 554,864 1.0% Mozambique 17,252 124,278 15% 48% 464,035 0.8% Congo-Kinshasa 7,062 92,137-79% 23% 1,401,078 2.6% Dominican Republic 9,180 87,935 3% 66% 344,157 0.6% Guinea 5,222 85,961 16% 59% 389,209 0.7% Rwanda 15,245 83,733 13% 59% 330,268 0.6% Haiti 9,793 83,118-6% 59% 315,380 0.6% Togo 1,207 71,388-47% 47% 417,901 0.8% Botswana 1,587 65,031 201% 189% 159,151 0.3% Swaziland 2,228 57,966 125% 102% 165,327 0.3% Senegal 4,353 57,810-6% 53% 204,273 0.4% Paraguay 7,275 54,557 0% 61% 210,908 0.4% Nicaragua 4,426 45,599 4% 59% 197,027 0.4% Burundi 3,972 34,788 64% 62% 96,768 0.2% El Salvador 3,159 32,943-6% 69% 179,158 0.3% Laos 5,927 31,047-7% 56% 125,811 0.2% Angola 8,198 29,296 20% 81% 131,323 0.2% Panama 1,949 25,737 22% 89% 77,398 0.1% Namibia 4,259 21,383-68% 46% 111,330 0.2% Honduras 2,732 20,158-4% 63% 80,835 0.1% Nepal 435 18,518-86% 9% 412,772 0.8% Thailand 207 7,740 80% 61% 28,189 0.1% Costa Rica 868 6,163-3% 52% 25,987 0.0% Cote d'ivoire 430 5,099-26% 121% 16,846 0.0% South Sudan 4,452-72% NA 67,078 0.1% Tajikistan 665 4,002 35% 64% 10,212 0.0% Liberia 3,229 10% 35% 14,269 0.0% Papua New Guinea 316 3,187-13% 69% 17,716 0.0% Caribbean 0 2,081 68% 39% 13,310 0.0% Somaliland 367 1,715 7% 65% 6,690 0.0% Belize 1,000-17% 51% 5,126 0.0% Kazakhstan 4 178 68% 89% 757 0.0% Kyrgyzstan 88-99% 71% 37,935 0.1% Viet Nam 46-18% 169,172 0.3% Russia NA NA 0.0% PSI GLOBAL 1,606,850 12,413,763-18% 55% 55,971,986 * 2014 program targets: 22,655,582 CYPs; we should be at 67% in August. Company 158** 54,718 442,431 11% NA 1,434,256 2.6% **included sales / distribution in Botswana, Lesotho, South Africa, and Swaziland. These sales / distribution are also included in the countries above. IMPACT DASHBOARD AUGUST 2014 5